SCHEMBL26075210

SCHEMBL26075210

CCOc1ccc(-c2ccc(-c3cc(C)c4cc(Cl)ccc4n3)cc2F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.47
▸ AURKB Q96GD4 1/20 0.47
▸ DHODH Q02127 5/20 0.47
▸ EHMT2 Q96KQ7 1/20 0.47
▸ KDM4E B2RXH2 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ HPGD P15428 2/20 0.46
▸ ACACA Q13085 1/20 0.43
▸ HMOX1 P09601 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ PLA2G2A P14555 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075130 0.89 HMOX1 (0.43) DHODHKDM4EALDH1A1HPGDHMOX1
SCHEMBL26075224 0.88 AURKA (0.62) AURKAAURKBDHODHKDM4EALDH1A1
SCHEMBL26075885 0.87 HMOX1 (0.41) KDM4EALDH1A1HPGDACACAHMOX1
SCHEMBL23590084 0.86 DHODH (0.67) AURKAAURKBDHODHKDM4EALDH1A1
SCHEMBL26075292 0.85 FEN1 (0.41) KDM4EALDH1A1HPGDHMOX1SMN1; SMN2
SCHEMBL26075298 0.83 HMOX1 (0.45) DHODHKDM4EALDH1A1HPGDHMOX1
SCHEMBL26075148 0.81 PDE10A (0.43) DHODHKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL26075339 0.81 DHODH (0.39) DHODHHMOX1PLA2G2A
SCHEMBL26075234 0.81 DHODH (0.44) DHODHPLA2G2A
SCHEMBL26075237 0.81 PLA2G2A (0.44) DHODHKDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD AURKA 3217/4885AURKB 2400/4885DHODH 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback